IFNA1 and neoplasm: PTR tumor variants treated with αIL6 showed significant tumor inhibition compared to P controls, but this inhibition was more muted than the more generalized PTIS blockade observed when IFN-signaling was disrupted (Fig. 7C, AUC analysis shown in inset; Fig. 7D, comparisons shown to respective controls).